Rob Dillard

DocwireNews

Using aspirin early may reduce the risk of in-hospital death in hospitalized patients with COVID-19, according to new study published in JAMA Network Open.This observational study consisted of 112,269 hospitalized patients (median age, 63) with moderate COVID. The study enrollment period was January 2020 through September 10, 2021, and focused on patients at 64 health systems in the U.S. participating in the National Institute of Health&rsquo;s National COVID Cohort Collaborative. In the population of interest, 16.1% of patients were African American, 3.8% were Asian, 52.7% were White, 5.0% were of other races and ethnicities, 22.4% were of unknown race and ethnicity. Researchers sought to assess the use of aspirin within the first day of hospitalization. The primary outcome of interest was defined as 28-day in-hospital mortality. Secondary outcomes were pulmonary embolism and deep vein thrombosis. In-hospital mortality was assessed using marginal structural Cox and logistic regression models.According to the results,&nbsp; in-hospital mortality occurred in 10.9% of patients. The researchers observed that 28-day in-hospital mortality was significantly lower in those who received aspirin (10.2% vs 11.8%; odds ratio [OR], 0.85; 95% CI, 0.79-0.92; P&thinsp;&lt;&thinsp;.001). Also, the second outcomes of pulmonary embolism, but not deep vein thrombosis, was also significantly lower in patients who received aspirin (1.0% vs 1.4%; OR, 0.71; 95% CI, 0.56-0.90; P&thinsp;=&thinsp;.004).<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Early Aspirin Use and In-Hospital Mortality in Patients With Moderate COVID-19 <a href="https://t.co/VmlBwj3x1a">https://t.co/VmlBwj3x1a</a> via <a href="https://twitter.com/JAMANetworkOpen?ref_src=twsrc%5Etfw">@JAMANetworkOpen</a> part of <a href="https://twitter.com/JAMANetwork?ref_src=twsrc%5Etfw">@JAMANetwork</a> Great collaboration between <a href="https://twitter.com/GWpublichealth?ref_src=twsrc%5Etfw">@GWpublichealth</a> <a href="https://twitter.com/GWSMHS?ref_src=twsrc%5Etfw">@GWSMHS</a> supported by <a href="https://twitter.com/CTSICN?ref_src=twsrc%5Etfw">@CTSICN</a>
&mdash; Keith Crandall (@crandallkeith) <a href="https://twitter.com/crandallkeith/status/1507017319813242883?ref_src=twsrc%5Etfw">March 24, 2022</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;The researchers concluded that &ldquo;aspirin use in the first day of hospitalization was associated with lower odds of 28-day in-hospital mortality and PE. Important subgroups that may benefit from aspirin included patients older than 60 years and those with comorbidities. Although the composite of hemorrhagic complications was not significantly higher in the early aspirin group, aspirin&rsquo;s risks must be carefully weighed before treatment. An RCT in a diverse patient population with high-risk conditions is needed to confirm our findings because our study cannot definitively establish causality.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Outstanding contribution from my good friend and colleague Jon Chow. The COVID anti-platelet controversy continues. Timing of initiation, comorbidities, and severity of illness are likely important factors. <a href="https://t.co/59FNw00uwh">https://t.co/59FNw00uwh</a>
&mdash; Michael Mazzeffi (@MMazzeffi) <a href="https://twitter.com/MMazzeffi/status/1507027219255861257?ref_src=twsrc%5Etfw">March 24, 2022</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;

Kaitlyn Kosko

Pembrolizumab Plus Trastuzumab/Pertuzumab Shows Promise in HER2-Positive Breast Cancer

HER2 Breast Cancer

MarkAlain Déry, DO, MPH, FACOI

Autism Rates Reach New High in U.S. Children: Here’s What It Really Means

Neurodivergent

Jordana Jampel

Annual US Measles Cases Top 1,000, Worst Year Since Elimination

Infectious Disease

Latest News

Does Aspirin Use Reduce the Risk of Death in COVID-19 Patients?

COVID-19

Using aspirin early may reduce the risk of in-hospital death in hospitalized patients with COVID-19, according to new study published in JAMA Network Open.
 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe